Search

everythinglearnresearchcommunity

for

Search:↓

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

The healthcare for transgender veterans could be better with a more unified team approach.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Hormones control reproduction and are crucial for body balance.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Skin symptoms can indicate endocrine disorders and have various treatments.